Dylan S. Young | People | Arnold & Porter

Dylan Young represents clients faced with complex antitrust issues. He has worked at all stages of complex litigation including trial, as well as merger and civil conduct investigations. Dylan has represented clients engaged in individual, multi-defendant, class action, and multi-district litigations. He has helped clients navigate a broad range of evolving areas of antitrust jurisprudence including platform competition, merger challenges, and no-poach agreements. Dylan has represented clients in dynamic industries including payments, publishing, technology, agriculture, telecommunications, and life sciences.

Focus Areas

Experience

Global payment card company in individual and national class actions in federal multidistrict litigation challenging interchange fees under the Sherman Act and state consumer protection statutes.
Global payment card company in federal antitrust class action litigation challenging ATM access fees under the Sherman Act and state consumer protection statutes.
Global payment card company in federal antitrust class action litigation challenging implementation of EMV under the Sherman Act and state statutes.
Global payment card company in federal antitrust litigation based on debit monopolization claims brought by competing debit network.
HarperCollins in private antitrust class action litigation brought against various book publishers and Amazon.

Mallinckrodt Pharmaceuticals in federal and state class action and non-class action litigation alleging antitrust and marketing-related claims regarding one of its leading products; obtained complete defense verdict at trial in bankruptcy proceeding, defeating certain antitrust and civil RICO claims.

Regional Care Associates, a physician practice of oncology and hematology specialists, in its entry into a strategic relationship with The U.S. Oncology Network, an affiliate of McKesson Corporation.
American Securities, a global private equity firm, in the sale of Milk Specialties Global, one of the leading suppliers of protein and other ingredients derived from dairy, to Butterfly Equity, a private equity firm specializing in the food sector.
Monsanto in connection with its US$66 billion acquisition by Bayer, which closed after a 20-month DOJ investigation. The transaction was reviewed and approved by antitrust enforcers in the U.S., the EU, and almost 30 other jurisdictions.
Cisco Systems Inc. in its US$1.9 billion acquisition of cloud-based unified communications provider BroadSoft, Inc., which was cleared without a Second Request by DOJ and without conditions worldwide.
Numerex, an Internet of Things (IOT) M2M enterprise solutions provider, in its sale to Sierra Wireless, a global device-to-cloud solutions provider.

Asylum seeker in wrongful death FTCA action against the U.S.
Immigration NGOs in a bench trial challenging discrimination in the census questionnaire; obtained complete result for plaintiffs.
Asylum seeker on appeal to uphold his release from detention by ICE without due process; obtained complete result for client.

Perspectives

February 2, 2024

What to Expect in 2024 Merger Enforcement: Trends and Developments from 2023 (pdf)

Newsletter

May 2023

Competition Litigation Comparative Guide - US Chapter

Mondaq

January 19, 2023

What to Expect in 2023 Merger Enforcement: Trends and Developments from 2022 (pdf)

Advisory

July 13, 2022

FTC Workshop Contemplates “New Approach” to Pharmaceutical Mergers

Advisory

January 31, 2022

What to Expect in 2022 Merger Enforcement: Trends and Developments from 2021 (pdf)

Advisory

More

Credentials

Education

J.D., The George Washington University Law School, 2016, with high honors, Order of the Coif
B.A., Political Science, Fordham University, 2013, summa cum laude, Phi Beta Kappa

Admissions

New York
District of Columbia
U.S. District Court, District of Columbia